A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa

PHASE2CompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

December 2, 2019

Primary Completion Date

January 10, 2022

Study Completion Date

January 10, 2022

Conditions
Acne Inversa
Interventions
DRUG

PF-06650833

400 mg QD

DRUG

PF-06700841

45 mg QD

DRUG

PF-06826647

400 mg QD

DRUG

Placebo

placebo

Trial Locations (77)

2010

Holdsworth House Medical Practice, Sydney

2217

Premier Specialists Pty Ltd, Kogarah

2606

Woden Dermatology, Phillip

3002

Sinclair Dermatology, East Melbourne

3053

Skin Health Institute Inc., Carlton

4102

Veracity Clinical Research, Woolloongabba

10029

Icahn School of Medicine at Mount Sinai, New York

17033

Penn State Health Milton S. Hershey Medical Center, Hershey

Penn State Health Radiology - University Physician Center, Hershey

19103

Paddington Testing Company, Inc, Philadelphia

19107

Thomas Jefferson University Hospital, Philadelphia

Thomas Jefferson University, Philadelphia

23298

Virginia Commonwealth University Medical Center, Richmond

30263

MedaPhase Inc., Newnan

30328

Advanced Medical Research PC, Sandy Springs

30677

Georgia Skin Cancer and Aesthetic Dermatology, Watkinsville

32073

Park Avenue Dermatology, Orange Park

32174

Leavitt Medical Associates of Florida d/b/a Ameriderm Research, Ormond Beach

32204

Total Dermatology Care Center, Jacksonville

32216

Jacksonville Center for Clinical Research, Jacksonville

33028

Riverchase Dermatology and Cosmetic Surgery, Pembroke Pines

33125

University of Miami Hospital, Miami

33162

Tory Sullivan MD PA, North Miami Beach

33613

ForCare Clinical Research, Tampa

33615

Alliance Clinical Research of Tampa, Tampa

33770

Olympian Clinical Research Largo Office, Largo

34470

Renstar Medical Research, Ocala

34471

MidState Skin Institute, Ocala

Renstar Medical Research, Ocala

35233

The University Of Alabama At Birmingham, Birmingham

35249

The University of Alabama at Birmingham Hospital Outreach Lab, Birmingham

The University of Alabama at Birmingham Investigation Drug Services Pharmacy, Birmingham

35294

The University of Alabama at Birmingham, Birmingham

38305

Clinical Research Solutions, Jackson

Dermatology and Skin Cancer Consultants, Jackson

38343

Dermatology and Skin Cancer Consultants, Humboldt

40241

DS Research, Louisville

46250

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

47129

Ds Research, Clarksville

48084

Revival Research Institute, LLC, Troy

48202

Wayne State University / Integrative Biosciences Center, Detroit

55455

Clinical Research Unit, Minneapolis

Lillihei Clinical Research Unit, Minneapolis

University of Minnesota Department of Dermatology, Minneapolis

60077

NorthShore University HealthSystem Dermatology Clinic, Skokie

63110

Saint Louis University - Department of Dermatology, St Louis

64506

MediSearch Clinical Trials, Saint Joseph

68144

Skin Specialists PC, Omaha

74136

Vital Prospects Clinical Research Institute, Tulsa

76011

Arlington Research Center, Arlington

78660

Austin Institute for Clinical Research, Inc., Pflugerville

84107

University of Utah MidValley Dermatology, Murray

85259

Mayo Clinic, Scottsdale

89052

J Woodson Clinical Studies Group, Henderson

90033

Keck School of Medicine of University of Southern California, Los Angeles

90404

Clinical Science Institute, Santa Monica

90806

Pacific Clinical Trials, Long Beach

94115

UCSF Dermatology Clinic, San Francisco

University of California San Francisco, San Francisco

94118

UCSF Psoriasis and Skin Treatment Center, San Francisco

94538

Center for Dermatology Clinical Research, Inc., Fremont

98004

Bellevue Dermatology Clinical Research Center, Bellevue

Bellevue Dermatology Clinic, Bellevue

98101

Dermatology Associates of Seattle, Seattle

06606

New England Research Associates, LLC, Bridgeport

06484

Dermatology Physicians of Connecticut, Shelton

02118

Boston Medical Center, Boston

Boston University General Clinical Research Unit, Boston

02215

Beth Israel Deaconess Medical Center, Boston

L4M 7G1

SimcoDerm Medical and Surgical Dermatology Center, Barrie

N6A 2C2

Manna Research (London), London

N6H 5L5

DermEffects, London

K9J 5K2

SKiN Centre for Dermatology, Peterborough

L4B 1A5

The Centre for Dermatology, Richmond Hill

J1L 0H8

Diex Recherche Sherbrooke Inc., Sherbrooke

G1W4R4

Centre de Recherche Saint-Louis, Québec

G2J 0C4

Alpha Recherche Clinique, Québec

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04092452 - A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa | Biotech Hunter | Biotech Hunter